Clinical Trial Update: Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) [NA]

View source ↗

Summary

The PULS-Pal trial is investigating personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer, and recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Head and Neck Carcinoma, Localized Head and Neck Carcinoma | NA | Status: RECRUITING